Consultant
2024 : 2024 : Consultant at Biodimed
2023-2024 : 1 year : Sanofi CHC France - Publci Affairs & Market access
2017-2023 : PharD Paris Cité University
1 year : MSD France - Market access (BU oncology)
6 months : AGEPS - Pharmaceutical Evaluations and Good Usage Department (PEGUD)
2022-2023 : Master’s degree in Market Access and Health economics evaluation, MAEME Paris-Saclay University
2021-2022: Inter-University Diploma in statistics-(CESAM) – Sorbonne University
2,5 years 'experience in market access (including industry and hospitals)
Market access including early access
TC Doctrine
Analysis and synthesis of clinical data
Oncology, immunology
SIRET : 81322123100042 RCS Paris – TVA intracommunautaire : FR21813221231 – SAS au capital de 5000 euros